EvokAI Creative Labs

EvokAI Creative Labs P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of EvokAI Creative Labs (OKAI.V) as of Nov 4, 2026 is -0.25. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -766.58 — a change of -99.97% (higher).

P/FCF

-0.25

YoY

-99.97%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of EvokAI Creative Labs is 2023 -0.25 . P/FCF (Price-to-Free-Cash-Flow Ratio) of EvokAI Creative Labs was 2022 -766.58 . It decreases by -99.97% higher compared to the previous year.

The EvokAI Creative Labs P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2020
-8.18 USD
Jan 1, 2021
-9.98 USD
Jan 1, 2022
-766.58 USD
Jan 1, 2023
-0.25 USD
The EvokAI Creative Labs P/FCF history
YEARP/FCFYoY
-0.25-99.97%
-766.58+7,579.37%
-9.98+22.05%
-8.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EvokAI Creative Labs Stock analysis

What does EvokAI Creative Labs do? EvokAI Creative Labs Inc develops AI algorithms for healthcare, deploying machine learning to search medical data and uncover insights for improved health outcomes. The company offers its AI solutions across the healthcare system, targeting hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, medical professionals, patients, and healthy individuals. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer, and EvokAI Medical, with EvokAI Simulators combining cognitive neuroscience, virtual reality, and AI to assess cognitive performance and spatial perception. The company generates revenue by providing AI-driven insights and tools to healthcare stakeholders, including pharmaceutical companies and research institutions, for drug development, clinical decisions, and disease prevention. EvokAI Simulators specifically serves medical professionals and patients seeking cognitive assessments through virtual reality and AI integration. EvokAI Medical supports healthcare providers in delivering accurate diagnoses and improving patient experiences. EvokAI Sensors and EvokAI Neurotrainer cater to diverse healthcare segments, from early disease detection to enhancing cognitive training. The company's focus on preventing and early detecting diseases aligns with the needs of aging populations and health-conscious individuals, driving demand for its AI-powered solutions across the healthcare ecosystem. EvokAI Creative Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EvokAI Creative Labs stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of EvokAI Creative Labs is -0.25 in 2023.

P/FCF (Price-to-Free-Cash-Flow Ratio) of EvokAI Creative Labs changed from -766.58 to -0.25, representing a -99.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) EvokAI Creative Labs since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s EvokAI Creative Labs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — EvokAI Creative Labs

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — EvokAI Creative Labs